|FOR IMMEDIATE RELEASE
CONTACT: LEWIS FEIN
use substandard generics could set back fight against AIDS
The French NGO has aggressively championed the usage of cheap Indian generics and, according to the Washington Post, MSF has put nearly 23,000 patients in 27 countries on these generic drugs. However, reacting to the news that Ranbaxy products were pulled form the market, an MSF spokesman Daniel Berman replied: “We are not worried for the safety of our patients. We are confident in the drugs we are using. We can’t make an equation that if a drug is removed from the list that it’s not a good drug.”
Interim Executive Director Lewis Fein commented, “Mr. Berman’s cavalier response to this serious drug recall is astounding. Why is MSF embracing the widespread use of what appears to be shoddy products? The effects of MSF’s malpractice will be clearly to have spawned new strains of HIV as a result of their highly politicized embrace of Indian generics.”
Public Interest Watch calls on MSF to provide answers to the following question:
Is MSF following provisions in the Human Declaration on Human Rights to obtain Informed Consent agreements from patients being administered generic drugs rather than branded products?